BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 29, 1998
View Archived Issues
Amylin announces results from pramlintide phase III studies
Read More
UCB acquires CytoMed assets and development pipeline
Read More
AERx Diabetes Management System enters phase II trials
Read More
ICN obtains rights to Senetek skincare cosmeceutical
Read More
Senetek licenses autoinjectable drug delivery system to ICN
Read More
Antiprogestin with potential as an oral postcoital contraceptive in women
Read More
Prostaglandin analogues attenuate ischemic liver damage in canine model
Read More
Selective ETA or mixed ETA/ETB antagonist for CHF?
Read More
Positive efficacy and safety results reported for IDEC-Y2B8/Rituxan in NHL
Read More
FDA clears first test for CMV DNA
Read More
Phase III study evaluates efficacy of tacrolimus in bone marrow transplantation
Read More
GlycoDesign and NRC agreement represents new approach to antibiotics
Read More
(+)-Enantiomer of known compound acts as potent, selective NMDA receptor antagonist
Read More
Novel class of vitamin D derivatives for metabolic bone diseases, psoriasis
Read More
Calpain inhibitors jointly developed by SKB and Cephalon
Read More
Difluoronucleoside antineoplastic and antiherpesvirus agents from Lilly
Read More
Astra's new antiasthmatic, antirhinitic agents
Read More
Thiocarbamic acid derivatives as inhibitors of squalene epoxidase
Read More
Positive initial clinical findings reported for first-generation GVAX vaccine for melanoma
Read More
AChE inhibition does not contribute to the neuroprotective effects of anseculin in vivo
Read More
Paralyzed mice regain the ability to walk following treatment with CM-101
Read More
Novel class of microtubule-destabilizing agents synthesized and evaluated at Kansas State
Read More
Addition of Remune increases efficacy of HAART in HIV-positive patients
Read More
CEA-Scan accurately detects breast cancer with low rate of false-positive results
Read More
European approval for Roche's sale of DePuy
Read More
CollaGenex seeks E.U.-wide approval of Periostat
Read More
